Gelareh Zadeh: How Does Molecular Classification Refine Surgical and Radiotherapeutic Decision Making in Meningioma?
Gelareh Zadeh, Dan Chair and Professor, Neurosurgery, University of Toronto shared a recent article by Justin Z. Wang on X, adding:
“With the highest accuracy the biomarkers we present in this work determine whether some one benefits from radiation therapy or not.”
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Authors: Justin Z. Wang, Vikas Patil, Alexander P. Landry, Chloe Gui, Andrew Ajisebutu, Jeff Liu, Olli Saarela, Stephanie L. Pugh, Minhee Won, Zeel Patel, Rebeca Yakubov, Ramneet Kaloti, Christopher Wilson, Aaron Cohen-Gadol, Mohamed A. Zaazoue, Ghazaleh Tabatabai, Marcos Tatagiba, Felix Behling, Damian A. Almiron Bonnin, Eric C. Holland, Tim J. Kruser, Jill S. Barnholtz-Sloan, Andrew E. Sloan, Craig Horbinski, Silky Chotai, Lola B. Chambless, Andrew Gao, Alexander D. Rebchuk, Serge Makarenko, Stephen Yip, Felix Sahm, Sybren L. N. Maas, Derek S. Tsang, The International Consortium on Meningiomas (ICOM), C. Leland Rogers, Kenneth Aldape, Farshad Nassiri and Gelareh Zadeh.
Source: Gelareh zadeh/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023